# Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults

> **NCT06414837** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 434 (estimated)

## Conditions studied

- Gout With Hyperuricemia in Adults

## Interventions

- **DRUG:** HR091506 tablets + placebo of febuxostat tablets
- **DRUG:** febuxostat tablets + placebo of HR091506 tablets

## Key facts

- **NCT ID:** NCT06414837
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 434 (ESTIMATED)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06414837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06414837, "Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06414837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*